U-Nanocure manufacturing campus

COMPANY PROFILE

COMPANY PROFILE ABOUT US

Jiangsu U-Nanocure Technology Co., Ltd. was established in 2016 and specialises in the R&D and manufacturing of minimally invasive medical devices. With R&D based in Nanjing and manufacturing based in Suqian, we have built a complete system covering development, production, sales and after-sales service, providing one-stop solutions for product development, registration, production, inspection, marketing and service.

U-Nanocure is committed to driving medical advancement through technology and continuous innovation. Its independently developed microwave ablation equipment holds 9 invention patents, 33 utility model patents, 4 design patents and 2 software copyrights, with leading domestic technology. Products cover oncology, interventional medicine, ultrasound, surgery and gynaecology, providing multidisciplinary solutions for hospital minimally invasive centres. The R&D team includes AI specialists and medical advisers from leading tertiary hospitals.

Guided by the belief of refined minimally invasive care, health focus and quality, we remain dedicated to our specialist field and to becoming an innovative medical-device enterprise driven by technology.

20000m²Production & testing centre
5000m²Medical-device GMP-certified facility
147processesControlled production processes
40checksLayered inspection checkpoints

DEVELOPMENT HISTORY

DEVELOPMENT HISTORY

2016

Company Established

Jiangsu U-Nanocure Technology Co., Ltd. was officially established.

2017

Product Breakthrough

Completed R&D and production transfer for microwave ablation products.

2018

First Registration

The microwave ablation antenna received its registration certificate.

2019

Focused R&D

Independently developed multiple proprietary technologies and processes.

2020

Patent Portfolio

Secured 9 invention patents, 33 utility model patents and 4 design patents.

2021

Clinical Progress

Completed clinical trials for selected products and began a new clinical research cycle.

2022

System Strengthening

Completed registration supplements and system assessments, and launched new R&D programs.

2023

System Launch

The microwave ablation system entered the market.

2024

Dual Breakthroughs

Recognised for R&D strength and accredited as a National High-tech Enterprise, SRDI enterprise and technology-based SME, achieving a breakthrough in non-powered products.

2025

Product Matrix Formed

Endovenous RF closure, high-frequency electrosurgical, puncture-guidance and RF ablation treatment products entered the market.

CORPORATE CULTURE

◎

CORPORATE
CULTURE

CULTURE

TOWARDS THE GOAL
BOUNDLESS FLIGHT

◎

Vision

To become a benchmark enterprise in minimally invasive interventional therapy, empowering medical progress through innovation and protecting patient health worldwide.

◉

Mission

Refined minimally invasive care. Focused on health. Built on quality. Making high-quality minimally invasive medical services accessible to more patients.

◇

Core Values

Continued focus. Specialist expertise. Steadfast dedication.